Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis

被引：0
|
作者：
Michael D Wiese
Matthew Schnabl
Catherine O'Doherty
Llewellyn D Spargo
Michael J Sorich
Leslie G Cleland
Susanna M Proudman
机构：
[1] University of South Australia,Sansom Institute for Health Research
[2] University of South Australia,School of Pharmacy and Medical Sciences
[3] Royal Adelaide Hospital,Department of Rheumatology
[4] Adelaide University,School of Medicine
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Triple Therapy; Leflunomide; Poor Metabolizers; Teriflunomide; Cytochrome P450 2C19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
    Wiese, Michael D.
    Schnabl, Matthew
    O'Doherty, Catherine
    Spargo, Llewellyn D.
    Sorich, Michael J.
    Cleland, Leslie G.
    Proudman, Susanna M.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (04)
  • [2] Cytochrome P450 2C19 genetic polymorphisms in Ugandans
    Miura, Jun
    Obua, Celestino
    Abbo, Catherine
    Kaneko, Sunao
    Tateishi, Tomonori
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (03) : 319 - 320
  • [3] Cytochrome P450 2C19 genetic polymorphisms in Ugandans
    Jun Miura
    Celestino Obua
    Catherine Abbo
    Sunao Kaneko
    Tomonori Tateishi
    European Journal of Clinical Pharmacology, 2009, 65 : 319 - 320
  • [4] Genetic Polymorphisms of Cytochrome P450 2C19 in Functional Dyspeptic Patients Treated with Cimetidine
    Kim, Minhee
    Kong, Eunhee
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2012, 16 (05): : 339 - 342
  • [5] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [6] THE SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) ASSOCIATED WITH CYTOCHROME P450 2C19 IN PATIENTS ON CLOPIDOGREL THERAPY
    Nazarene, A.
    Chandar, C. S. Ravi
    Kumar, A. M.
    Nagarajan, B.
    Govindarajan, S. R.
    Ranganathan, L. N.
    S, G.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 113 - 113
  • [7] GENETIC POLYMORPHISM OF CYTOCHROME P450 (2C19) IN PATIENTS WITH RENAL TRANSPLANT
    Ciftci, Hayriye Senturk
    Tefik, Tzevat
    Turkmen, Aydin
    Nane, Ismet
    Oguz, Fatma Savran
    Aydin, Filiz
    TISSUE ANTIGENS, 2014, 84 (01): : 58 - 59
  • [8] Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke
    Jung, Yo Han
    Song, Tae-Jin
    Kim, Jinkwon
    Park, Hee-Kwon
    Han, Sang Won
    Kim, Young Dae
    Park, Jong-Ho
    Cha, Jae-Kwan
    Park, Hyun Young
    Sohn, Sung-Il
    Yu, Sungwook
    Lee, Jun Hong
    Shin, Dong Hoon
    Kim, Eung-Gyu
    Lee, Hye Sun
    Lee, Kyung-Yul
    JAMA NETWORK OPEN, 2025, 8 (04)
  • [9] Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism A retrospective study
    Naujokaitis, Domas
    Asmoniene, Virginija
    Kadusevicius, Edmundas
    MEDICINE, 2021, 100 (11) : E24545
  • [10] Association between cytochrome p450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese
    Yasui-Furukori, Norio
    Kaneda, Ayako
    Iwashima, Kumiko
    Saito, Manabu
    Nakagami, Taku
    Tsuchimine, Shoko
    Kaneko, Sunao
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (06) : 724 - 727
12345